Cincinnati Univ Of

Cincinnati Univ Of's Sponsored Research Services Division, a state-controlled public research institution based in Cincinnati, Ohio, operates as a prime recipient of federal research grants and prime contractor on federal research agreements, delivering basic and applied research across biomedicine, environmental science, materials science, and engineering to 204 distinct federal agencies. The Division is not a commercial vendor and does not compete under small-business set-asides; it functions as a major academic research enterprise with a diversified portfolio spanning competitive research funding from civilian agencies, defense research, and government-wide indefinite-delivery contract task orders.

The Division's concrete capability footprint centers on pre-clinical and clinical research in infectious diseases, cardiovascular science, oncology, neuroscience, and respiratory health; environmental and water-resources research; materials science and advanced manufacturing; and educational programs spanning STEM workforce development and postsecondary education. Its flagship institutional capacity is anchored by a single-award Indefinite Delivery Contract valued at $146.3 million from the National Institute of Allergy and Infectious Diseases, running through July 2031, under which the Division develops, refines, and employs animal and cell-based pre-clinical models of infectious diseases—including emerging pathogens with pandemic potential, antimicrobial-resistant organisms, and neglected tropical diseases—to support screening and evaluation of vaccines, therapeutics, and diagnostics. Representative research awards include a $1.72 million translational grant from the National Institute on Drug Abuse on single-cell opioid responses in HIV-infected populations; a $3.87 million grant from the National Institute of Environmental Health Sciences on PFAS hepatotoxicity mechanisms; a $898,039 Office of Naval Research contract for rotating detonation combustion technology; and cooperative agreements with the U.S. Air Force totaling $2.3 million on medical operations research and blood-product filtration strategies. The Division also holds numerous smaller task orders under Navy and Army IDCs, including a $19,880 Army Corps of Engineers contract on climate-resilience hydrologic modeling in Argentina and multiple Veterans Affairs contracts for blood products, IRB oversight, and bioskills laboratory services.

Customer concentration reflects the Division's role as a major NIH research institution. The National Institute of Allergy and Infectious Diseases (84 awards, $237.9 million combined potential value) and the Veterans Integrated Service Network 10 (119 awards, $63.1 million) dominate the top-value rankings; the National Science Foundation (402 awards), NIH broadly (362 awards), and the Air Force (134 awards) lead by award count. The Division served 204 agencies across the source period; the top five customer agencies by potential value account for 56% of combined potential value, indicating moderate concentration driven by the NIAID IDIQ anchor contract and substantial NIH extramural research funding.

The Division's activity has grown significantly, from 170 awards in 2022 to 271 in 2024, with a recent decline to 63 awards in 2025 (first five months) reflecting the source data cutoff. Combined dollars obligated ($3.53 billion) exceed combined potential value ($672.1 million) by 525%, a pattern typical of mature academic research institutions where multiple-year grants and contracts accumulate obligated funds across their life spans. Recompete exposure in the next 24 months totals $13.9 million across 203 awards—a modest concentration reflecting the long-term nature of NIH research grants (typically 3–5 years) and the single large NIAID IDIQ.

The Division operates predominantly as a prime (88% of awards) across research grants and contracts; it functions as a sub-recipient or subcontractor on clinical trials, collaborative research projects, and imaging/data-coordination centers managed by peer institutions (Johns Hopkins, Columbia, Yale, Stanford, and others). SCI-reported federal service-contract activity is minimal ($2.4 million invoiced across FY2022–FY2024) and reflects the institution's grant-dominant funding model rather than time-and-materials service contracting. Government-paid hourly rates on SCI-reportable contracts run a median of $3,180.63/hr with senior research rates reaching $23,152/hr.

The Division's award footprint spans research, tuition support for military and civilian agency personnel, blood products and transfusion services for the Veterans Administration, educational programming (STEM workforce development, teacher training, civil discourse), and infrastructure projects (water resources, hydrologic modeling, semiconductor manufacturing workforce preparation). It operates globally and domestically, with performance sites at the Cincinnati campus and subordinate research locations. As a university division, the entity does not hold parent contract vehicles (GWACs, BPAs) in the traditional commercial sense; it is awarded work under agency-specific IDIQs and research grant programs. Its pipeline is characterized by continuous competitive research proposal submissions to NIH institutes, NSF directorates, DoD research offices, and NASA, with award rhythms tied to NIH review cycles (typically two submission windows per year) and individual agency solicitation schedules.